Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maryland for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maryland only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maryland (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Mohit Narang (NPI 1881695351)

Field	Value
Entity Type	Individual
Organization	Mohit Narang
Address	23 Crossroads Drive
City	Owing Mills
State	MD
ZIP	21117
Taxonomy	Medical Oncology Physician
NPI Enumerated	August 9, 2005

Payer Source	Total Paid
Medicare	$3M
Medicaid	$0

Key Findings

MOHIT NARANG’s billing profile is consistent with an oncology infusion practice that relies heavily on high-cost biologic and immunotherapy injections alongside outpatient chemotherapy administration. The single largest revenue line is J9271 (pembrolizumab) at $1.1M (36.6% of Medicare revenue), supported by additional immunotherapy and specialty oncology drugs such as J9144 (daratumumab, $478.8K) and J9299 (nivolumab, $246.7K), plus procedural chemotherapy codes like 96413 ($56.3K).

Revenue concentration is high: the top 3 Medicare codes by revenue account for 62.6% of this provider's total Medicare revenue, while total Medicare revenue is $3M and there is no Medicaid billing on file. This indicates that a small number of injectable oncology agents drive the majority of billed Medicare dollars for this NPI.

This provider is effectively single‑payer in the dataset: Medicare shows $3M in lifetime revenue and the provider has no Medicaid billing on file. The absence of Medicaid billing makes the practice heavily dependent on Medicare reimbursement and utilization patterns.

Competitive standing is mixed across codes. For J9271 the provider ranks #229 of 1841 nationally (87th percentile; typical, unremarkable volume for this code), for J9144 the provider ranks #137 of 615 (78th percentile; typical), while J0897 (denosumab) shows a much stronger relative presence at #514 of 10057 (95th percentile; notably above typical national volume), and J1437 (ferric derisomaltose) ranks #21 of 581 (96th percentile; notably above typical national volume), indicating pockets of above‑average national activity on certain specialty injections.

Utilization and service mix indicate both infusion throughput and longitudinal outpatient management. High-volume lab and monitoring activity is suggested by 80053 (CMP) with 2.5K claims and $25.1K revenue (rank #507 of 26416, 98th percentile) and 85025 (CBC) with 2.1K claims and $17.1K revenue (rank #906 of 32833, 97th percentile), supporting in‑office monitoring tied to frequent parenteral therapies.

There are notable statistical outliers in E/M and supportive therapy patterns. The provider reports 1.2K claims for 99214 totaling $118.3K (4.1% of Medicare revenue) and ranks #7624 of 479517 (98th percentile; extreme outlier, far above typical national volume for this code), suggesting unusually high utilization of established‑patient outpatient visits relative to peers; concurrently, J0881 shows very large claim volume (43.3K claims, $86.6K revenue) at a low average payment per claim, indicating use of high-frequency, low-value supportive medications.

Tenure data show this NPI was enumerated on 2005-08-09 (~21 years ago), reflecting a long-established billing history. This longevity is consistent with an entrenched outpatient oncology practice likely integrated into local referral patterns.

From a payor and operational risk perspective, the provider’s heavy reliance on a few high-cost injectable drugs (e.g., J9271 at $1.1M) and the lack of Medicaid billing create concentration exposure: changes in Medicare drug coverage, utilization management, or pricing for those agents could meaningfully affect revenue, while the absence of Medicaid limits diversification opportunities in the short term.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

66 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	24,800	$40	$1.1M
J9144	Injection, daratumumab, 10 mg and hyaluronidase‑fihj	12,600	$40	$478.8K
J0897	Injection, denosumab, 1 mg	15,360	$20	$276.5K
J9299	Injection, nivolumab, 1 mg	10,280	$20	$246.7K
J1437	Injection, ferric derisomaltose, 10 mg	11,200	$20	$190.4K
J9047	Injection, carfilzomib, 1 mg	4,110	$40	$148K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,170	$100	$118.3K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	43,300	$1	$86.6K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	500	$110	$56.3K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	350	$130	$45.3K

Showing 1–10 of 66

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 66 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maryland Distribution

Mohit Narang — 5 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maryland

Full comparison — all codes billed, vs. state median

66 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	17	60	15,000	$40	$787.6K
J9299	21	20	24,080	$20	$660.6K
J9144	12	30	11,970	$40	$493.5K
J9047	2	10	5,640	$40	$202.6K
J0897	30	340	3,600	$20	$114.4K
J0881	20	60	30,420	$1	$76.4K
J1437	3	50	2,800	$20	$75.1K
J3490	38	100	70	$450	$62.1K
96413	36	230	200	$110	$29.6K
J9217	14	100	150	$130	$27.3K

Showing 1–10 of 66

Related Providers

Other providers that share a Tax Identification Number (TIN) with Mohit Narang, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Maryland Oncology Hematology P.A.	MD	Hematology & Oncology Physician	$0	$4.6M
Kashif Ali	MD	Hematology & Oncology Physician	$3.6M	$0
Andrew Mener	MD	Hematology & Oncology Physician	$3.5M	$0
Jason Taksey	MD	Medical Oncology Physician	$3.3M	$0
Frederick Min	MD	Hematology & Oncology Physician	$3.2M	$0
Frederick Smith	MD	Medical Oncology Physician	$2.7M	$0
Deepnarayan Tiwarri	MD	Hematology & Oncology Physician	$2.6M	$0
Amr Hegazi	MD	Hematology & Oncology Physician	$2.3M	$0
Edward Lee	MD	Medical Oncology Physician	$1.9M	$0
Ravin Garg	MD	Hematology & Oncology Physician	$1.9M	$0

Nearby Providers

Other providers in the same ZIP code as Mohit Narang, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Advanced Radiology P A	MD	Diagnostic Radiology Physician	$0	$41.4M
Maximum Day Services, LLC	MD	Adult Day Care Clinic/Center	$0	$19.1M
Lifeway Adult Medical Day Center, LLC	MD	Adult Day Care Clinic/Center	$0	$15.7M
Maximum Day Services Ii, LLC	MD	Adult Day Care Clinic/Center	$0	$13.5M
All Staffing, Inc.	MD	Home Health Agency	$0	$12.6M
Adult Day Health, Inc.	MD	Adult Day Care Clinic/Center	$0	$12.4M
Progress Unlimited Medical Adult Day Program And Wellness Center	MD	Adult Day Care Clinic/Center	$0	$11.1M
Gaudenzia Inc	MD	Substance Use Disorder Rehabilitation Clinic/Center	$0	$9.3M
Advanced Pain Management Specialists, LLC	MD	Clinical Medical Laboratory	$0	$8.8M
Patient First Maryland Medical Group PLLC	MD	Family Medicine Physician	$0	$8.7M

Mohit Narang — Billing Profile & Reimbursement Data

Sign up for Mohit Narang — Billing Profile & Reimbursement Data policy alerts

Mohit Narang — Billing Profile & Reimbursement Data

Sign up for Mohit Narang — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References